Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting No phase listed Observational

Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A

ClinicalTrials.gov ID: NCT03432520

Public ClinicalTrials.gov record NCT03432520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center Evaluation of the Long-Term Safety and Efficacy of Spark-sponsored Gene Therapies in Males With Hemophilia A

Study identification

NCT ID
NCT03432520
Recruitment status
Active, not recruiting
Study type
Observational
Phase
Not listed
Lead sponsor
Spark Therapeutics, Inc.
Industry
Enrollment
29 participants

Conditions and interventions

Conditions

Interventions

  • SPK-8011 Genetic
  • SPK-8016 Genetic

Genetic

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 13, 2018
Primary completion
Nov 30, 2032
Completion
Nov 30, 2032
Last update posted
Nov 28, 2024

2018 – 2032

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
Boston Children's Hospital Boston Massachusetts 02115
Mississippi Center for Advanced Medicine Madison Mississippi 39110
Truman Medical Centers Kansas City Missouri 64108
Oregon Health & Science University Portland Oregon 97239
Pennsylvania State University Milton S. Hershey Medical Center Hershey Pennsylvania 10733
The Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104
Thomas Jefferson University Philadelphia Pennsylvania 19107
Hemophilia Center of Western Pennsylvania Pittsburgh Pennsylvania 15213
Virginia Commonwealth University Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03432520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03432520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →